SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-672042
Filing Date
2016-08-04
Accepted
2016-08-04 17:26:59
Documents
66
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d201221d10q.htm 10-Q 473511
2 EX-10.1 d201221dex101.htm EX-10.1 3651
3 EX-31.1 d201221dex311.htm EX-31.1 8144
4 EX-31.2 d201221dex312.htm EX-31.2 8122
5 EX-32.1 d201221dex321.htm EX-32.1 3894
12 GRAPHIC g201221g0728110215928.jpg GRAPHIC 3468
  Complete submission text file 0001193125-16-672042.txt   3432101

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cara-20160630.xml EX-101.INS 677303
7 XBRL TAXONOMY EXTENSION SCHEMA cara-20160630.xsd EX-101.SCH 39755
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20160630_cal.xml EX-101.CAL 55511
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20160630_def.xml EX-101.DEF 138247
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20160630_lab.xml EX-101.LAB 333278
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20160630_pre.xml EX-101.PRE 241590
Mailing Address ONE PARROTT DRIVE SHELTON CT 06484
Business Address ONE PARROTT DRIVE SHELTON CT 06484 203-567-1500
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 161808522
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences